Π‘ΠΈΠ½ΡΠ΅Π· ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π½ΠΎΠ²ΡΡ 1, 2, 4-ΡΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°
Posner G. II., Park S. Π., Gon/alez L. et al. Evidence for the importance of high-valent Fe=0 and of a diketone in the molecularmechanism of action of antimalarial trioxane analogs of artemisinin. //J. Am. Chem. Soc. 1996. — 118. — p. 3537β3538. Mirjalili Π. F, Zolfigol M. Π., Bamoniri A., Zarei A. Silica sulfuric acid/potassium permanganate/wet S1O2 as an efficient heterogeneous method for the… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π²Π²ΠΏΠ΄Π½Π½ΠΈΠ½
- 1. ΠΠΠ’ΠΠ ΠΠ’Π£Π 11Π«Π ΠΠΠΠΠ
- 1. 1. ΠΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½
- 1. 2. ΠΠΎΠ»Π½ΡΠΉ ΠΈ ΡΠ°ΡΡΠΈΡΠ½ΡΠΉ ΡΠΈΡΠ΅? Π°Ρ1Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°
- 1. 3. Π‘ΠΈΡΠ΅* ΠΏΡΠΎΠΈ{Π²ΠΎΠ΄Π½ΡΡ ΠΈ ΡΠΏΡΠΎΡΠ΅Π½Π½ΡΡ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°
- 1. 4. ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π°Π½ΡΠΌΠ°Π»ΡΡΠΈΠΉΠ½ΠΎΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΡΠ½Π΄ΠΎΠ½Π΅ΡΠΎΠΊΡΠΈΠ΄Π½ΡΡ ΠΏΡΠ΅Π½Π°ΡΠ°Π³ΠΎΠ²
- 1. 5. ΠΠΈΠΌΠ΅ΡΡΠΈ ΡΠΈΠΌΠ΅ΡΡ Π°Ρ Π³Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΠ΅ Π°ΡΠΈΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°Π³ΠΈΠ²Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΠ΅ 1ΡΠΎ
- 2. Π₯ΠΠΠΠ§ΠΠ‘ΠΠΠ― Π§ΠΠ‘ Π
- 2. 1. Π‘ΠΈΡΠ΅Π· Π½ΠΎΠ²ΡΡ 3-Π°ΡΠΈΠ»Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ 1,2,4-ΡΠΈΠΎΠΊΠ΅Π°Π½ΠΎΠ²ΡΡ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² 83 Π°ΡΠ³Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π° Π΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π³ΡΠΈΡΠ΅Π½ΠΈΠ»ΡΠΎΡΡΠΈΡΡΠ½ΠΈΠ΄Π° Π² ΠΊΠ°ΡΠ΅Ρ I Π²Π΅ Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ ΠΎ ΡΠΊΠ²ΠΈΠ²Π°Π»Π΅Π½ i, Π° ΡΠΈΠ½Π³Π»Π΅ i Π½ΠΎΠ³ ΠΎ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π°
- 2. 2. Π‘ΠΈΠ½ΡΠ΅Π· Π΄ΠΈΠ°Π΅Π³Π΅ΡΠ΅ΠΎΠΌΠ΅ΡΠ½ΠΎ ΡΠΈΡΡΠΎΡ, ΡΠ°ΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΡ 1,2,4ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΠΎΡ Π΄ΠΈΠΌΠ΅ΡΠ°, ΡΡ ΠΎΠ΄Π½ΠΎΡ Ρ Π΄ΠΈΠΌΠ΅ΡΠ°ΠΌΠΈ ΠΏΡΠΈΡΠΎΠ΄Π½ΠΎΠ³ΠΎ Π°ΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΠΌΠΈ Π°Π½ΡΠΈΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ
- 2. 3. Π‘ΠΈΠ½ΡΠ΅Π· ΡΠ°ΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΡ Π³ΡΠΈΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ 1,2,4-ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ², ΠΈΠ·ΠΎΠΌΠ΅ΡΠ½ΡΡ ΡΠΏΡΠΎΡΠ΅Π½Π½ΡΠΌ Π°Π½Π°Π»ΠΎΠ³Π°ΠΌ Π°ΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°
2.4 Π‘ΠΈΡΠ΅Π· ΠΈ ΠΈΠ½Π΄ΡΡΠΈΡΡΠ΅ΠΌΠ°Ρ Fe (II) Π΄Π΅Π³ΡΠ°Π΄Π°ΡΠΈΡ 3- 104 ΡΠΈΠΊΠ»ΠΎΠΏΡΠΎΠΏΠΈΠ»Π·Π°ΠΌΠ΅ΡΠ΅Π½ΠΏΠΎΠ³ ΠΎ 1,2,4-Π³ΡΠΈΠΎΠΊΡΠ°Π½ΠΎ1ΡΠ³ ΠΎ Π°Π½Π°Π»ΠΎΠ³, Π° Π°ΡΡΡΠΌΠΈΡΠ½ΠΈΠ½Π° ΠΊΠ°ΠΊ ΡΠΏΠΎΡΠΎΠ± ΠΏΡΠΎΠ²Π΅ΡΠΊΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΡΡΠΈ Π°Π»ΡΡΠ΅ΡΠ½Π°ΡΠΈΠ²Π½ΡΡ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² Π°Π½ΡΠΈΠΌΠ°Π»ΡΡΠΈΠΉΠ½ΠΎΡ Π΄Π΅ΠΉΡΠ³Π²ΠΈΡ Π΄Π°Π½Π½ΠΎΡ Π³ΠΈΠ½Π° ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ.
2.5 Π‘ΠΈΠ½ΡΠ΅Π· 12-Π±Π΅Π½ΡΠ»ΠΎΠΊΡΠΈΠ·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ 1,2,4-ΡΠΈΠΎΠΊΠ΅Π°Π½ΠΎΠ²ΡΡ 110 Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΠ³Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π° Ρ ΡΠΈΡΠΎΠΊΠΈΠΌ ΠΏΡΠΎΡΠΈΠ»Π΅ΠΌ Π»ΠΈΠ½ΠΎΠ»ΡΠ½ΠΎΡΠ³ΠΈ
2.6 ΠΠΎΠΈΡΠΊ ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΡ ΠΏΠΎΠ΄Ρ ΠΎΠ΄Π° ΠΊ ΡΠΈΡΠ΅? Ρ 3-(Ρ- 120 ΠΊΠ°ΡΠ±ΠΎΠΊΡΠΈΡΠ΅Π½ΠΈΠ») ΡΠΌΠ΅ΡΠ΅Π½Π½ΡΡ 1,2,4-Π³ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ² Π΄Π»Ρ Π΄ΠΎΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΠΏΡΡΠ°Π½ΠΈΡ Π½Π° ΡΡΡΠ·ΡΠ³Π³Π°Ρ
2.7 ΠΠΎΠ²ΡΠ΅ 1,2,4-ΡΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΠ΅ Π°Π½Π°Π»ΠΎΠ³ΠΈ Π°Ρ 1Π΅ΠΌΠΈΡΠ½ΠΈΠ½Π°, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΠ΅ 126 ΡΡΠ»ΡΡΠΈΠ΄Π½ΡΠΉ ΠΈ ΡΡΠ»ΡΡΠΎΠ½ΠΎΠ²ΡΠΉ ΡΡΠ°ΡΠ΅ΡΡ ΠΏΡΠΈ Π‘-12. Π‘ΠΈΡΠ΅Π·, Π°ΡΠΈΠΌΠ°Π»ΡΡΠΈΠΉΠ½Π°Ρ Π°ΠΊΡΠ²Π½ΠΎΡΡΡ ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅
Π²ΡΠ²ΠΎΠ΄Ρ ΠΎΠ³Π½ΠΎΡΡΠ΅Π»ΡΠ½ΠΎ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠ° Π±ΠΈΠΎΠ»ΠΎ1ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ.
ΠΠΠ‘1 1ΠΠ ΠΠΠ1 ΠΠΠΠΠ« 1ΠΠ― Π§ΠΠ‘Π’Π¬
3.1 Π Π΅Π°ΠΊΡΠΈΠ²Ρ, ΡΠ°Ρ ΡΠΎΡΠΈ Π³Π΅Π»ΠΈ, Π°Π½Π°Π»ΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π±Π°Π·Π°
3.2 ΠΠ±ΡΠΈΠ΅ ΠΌΠ΅ΡΠ΄ΠΈΠΊΠΈ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ Π² ΡΠ°Π±ΠΎΡΠ΅
3.3 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.
3.4 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.
3.5 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.
3.6 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.
3.7 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.
3.8 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.
3.9 ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΊ ΡΠ°Π·Π΄Π΅Π»Ρ 2.7 166 OCHOBI ΠͺΠ¨ Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π« Π ΠΠΠΠ’Π« Π
ΠΠ«ΠΠΠΠ« 169 ΠΠ ΠΠΠ Π’ΠΠ£Π Π
Π‘ΠΈΠ½ΡΠ΅Π· ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π½ΠΎΠ²ΡΡ 1, 2, 4-ΡΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π° (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
ΠΠ‘ΠΠΠΠΠ«Π Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π« Π ΠΠΠ Π’Π« Π ΠΠ«ΠΠΠΠ«.
1. ΠΠΏΡΠΎΠ±ΠΈΡΠΎΠ²Π°Π½Π° ΠΌΠ΅ΡΠ΄ΠΎΠ»ΠΎ1ΠΈΡ ΡΠΈΠ½ΡΠ·Π° 1,2,4-ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π°Π½Π°Π»ΠΎΡΠ² Π°ΡΡΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π° ΠΈΠ· Π΅Π½ΠΎΠ»ΡΡΠΈΡΠ½ΡΡ ΠΊΠ΅ Π³ΠΎΠ½ΠΎΠ² Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠΈΡΠ΅Π½ΠΈΠ»ΡΠΎΡΡΠΈΡΠ·ΠΎΠ½ΠΈΠ΄Π° Π² ΠΊΠ°ΡΠ΅ΡΠΏΠ·Π΅ ΡΠΈΡΠ΅ΡΡΠ΅ΡΠΊΠΎΡ ΡΠΊΠ²ΠΈΠ²Π°Π»Π΅Π½ΡΠ° ΡΠΈΠ½Π³Π»Π΅ ΡΠΎΡ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π°. Π ΡΠ°ΠΌΠΊΠ°Ρ ΡΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎ1ΠΈΠΈ Π½Π°ΠΌΠΈ Π±ΡΠ»ΠΈ ΡΡΠΏΠ΅ΡΠ½ΠΎ ΡΠΈΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ 3-Π°ΡΠΈΠ» Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ ΡΠΈΠΎΠΊΡΠ°Π½Ρ, ΠΏΠΎΠΊΠ°Π·Π°Π²ΡΠΈΠ΅ Π²ΡΡΠΎΠΊΡΡ Π°Π½Π³ΠΈΠΌΠ°Π»ΡΡΠΈΠΉΠ½ΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ib Π½Π° ΡΡΠΎΠ²Π½Π΅ ΠΏΡΠΈΡΠΎΠ΄Π½ΠΎΠΉ) Π°ΡΡΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°. ΠΡΠ΄Π΅Π»Π΅Π½Ρ ΠΈ ΠΈΠ΄Π΅ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Ρ ΠΏΠΎΠ±ΠΎΡΠ½ΡΠ΅ ΠΏΡΠΎΠ΄ΡΠΊ1Ρ Π΄Π°Π½Π½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ: ΠΎΠΆΠΈΠ΄Π°Π΅ΠΌΡΠΉ Π² ΡΠ°ΠΌΠΊΠ°Ρ ΠΈ ΡΠ΅Π΅ ΡΠΎΠ³ΠΎ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠ° Π°,|3-Π½Π΅ΠΈΡΠ΅Π΄Π΅Π»ΡΠ½ΡΠΉ Π°Π»ΡΠ΄Π΅Π³ΠΈΠ΄, Π° ΡΠ°ΠΊΠΆΠ΅ Π½Π΅ΠΎΠΆΠΈΠ΄Π°Π½Π½ΡΠΉ 1,3-Π΄ΠΈΠΎΠΊΡΠΎΠ»Π°Π½ΠΎΠ²ΡΠΉ ΠΏΡΠΎΠ΄ΡΠΊΡ, Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎ ΡΡΠΎΡ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½.
2. ΠΠΎΠΊΠ°Π·Π°Π½Π° Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ·ΠΎΠΌΠ΅ΡΠ½ΡΡ Π΅Π½ΠΎΠ»ΡΡΠΈΡΠ½ΡΡ ΠΊΠ΅ Π³ΠΎΠ½ΠΎΠ² Π² ΡΠΈΡΠ΅Π·Π΅ ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΡΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π° ΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½ ΡΡΡΠ΅ΠΊΡΠ²Π½ΡΠΉ ΠΌΠ΅ΡΠ΄ ΡΠΈΠ½Ρ Π³Π° ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΡ . Π Π°Π·ΡΠ°Π±ΠΎ1Π°Π½Π½ΠΌΠΉ Π½Π°ΠΌΠΈ ΡΠΈΠ½ΡΡΡΠ΅ΡΠΊΠΈΠΉ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ ΠΊ «ΠΈΠ·ΠΎΠΌΠ΅ΡΠ½ΡΠΌ» 1,2,4-ΡΠΈΠΎΠΊΡΠ°Π½Π°ΠΌ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ°ΡΡΠΈΡΡΠ΅Ρ ΠΊΡΡΠ³ ΡΠΈΡΠ΅ΡΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΡΠΏΠ½ΡΡ Π½ΠΎΠ²ΡΡ ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ ΡΡΡΠΊΠ³ΡΡ. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° Π½ΠΈΠ³ΠΊΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π°ΡΠΈΠΌΠ°Π»ΡΡΠΈΠΉΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, Π½Π°Π±Π»ΡΠ΄Π°Π΅ΠΌΡΠ΅ Π΄Π»Ρ Π΄Π°Π½Π½ΡΡ (Π²ΠΏΠ΅ΡΠ²ΡΠ΅ ΡΠΈΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ) ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ΅Π³ΡΠ»ΡΡΡ ΠΎΡΠΊΡΡΠ²Π°ΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π΄Π»Ρ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΡ Π²Π·Π°ΠΈΠΌΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΉ «ΡΠ³ΡΡΠΊ1ΡΡΠ°-Π°ΠΊ1ΠΈΠ²Π½ΠΎΡ1Π¬» Π² ΡΡΠ΄Ρ «ΠΈΠ·ΠΎΠΌΠ΅ΡΠ½ΡΡ » ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ Moiyi Π±ΡΠΏΡ ΡΠΎΠ²Π΅ΡΡΠ΅Π½Π½ΠΎ ΠΈΠ½ΡΠΌΠΈ, ΡΠ΅ΠΌ Π΄Π»Ρ ΡΡΠ΄Π° «Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ » 1,2,4-ΡΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ², ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π²ΡΠΈΡ ΡΡ ΡΠ°Π½Π΅Π΅.
3. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½ ΠΌΠ΅ΡΠ΄ ΡΠΈΡΠ΅Π·Π° Π‘Π·-Π‘Π·'-(/7-ΡΠ΅Π½ΠΈΠ»ΠΈΠ΄Π΅Π½)-ΡΠ²ΡΠ·Π°Π½Π½ΠΎΡ 1,2,4-ΡΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΠΎΡ Π΄ΠΈΠΌΠ΅ΡΠ°, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠ΅Ρ Π·Π°ΠΌΠ΅ΡΠ½ΠΎΠΉ Π°ΡΠΈΠΌΠ°Π»ΡΡΠΈΠΉΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ Π΄Π²ΡΡ ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π΅Π΄ΠΈΠ½ΠΈΡ ΠΏΠ΅ΡΠ΅Π³ΡΡΠΏΠΏΠΈΡΠΎΠ²ΠΊΠΎΠΉ 1,2-Π΄ΠΈΠΎΠΊΡΠ΅Π³Π°Π½ΠΎΠ²ΠΎΡ ΠΈΡΠ΅ΡΠΌΠ΅Π΄ΠΈΠ°ΡΠ° Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ Π²Π½ΡΡΡΠΈ ΠΎΠ΄Π½ΠΎΠΉ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠΉ ΠΌΠ΅ΡΠ΄ ΡΠΈΡΠ΅Π·Π° ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΏΠΎΠ»ΡΡΠ°Π³Ρ Π°ΡΠΈΠΈΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ½ΡΠ΅ Π΄ΠΈΠΌΠ΅ΡΡ ΠΏΠΎΠ΄ΠΎΠ±Π½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ ΠΏΡΡΠ΅ΠΌ Π²Π°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΏΠ° ΠΈ ΡΠ°Π·ΠΌΠ΅ΡΠΎΠ² «ΠΌΠ΅ΠΆΡΠΈΠΎΠΊΠ΅Π°Π½ΠΎΠ²ΠΎΡ» ΡΠ²ΡΠ·ΡΡΡΠ΅Ρ ΡΡΠ°Π³ΠΌΠ΅Π½Ρ.
4. Π Π°Π·ΡΠ°Π±ΠΎΡΠ½Ρ ΡΠΈΡΠ΅ΡΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠ΄Ρ ΠΎΠ΄Ρ ΠΊ Π½ΠΎΠ²ΡΠΌ 1,2,4-ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΠΌ Π°Π½Π°Π»ΠΎΠ³Π°ΠΌ Π°ΡΠ³Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°, ΡΠ³ΡΡΠΊΠ³ΡΡΠ° ΠΊΠΎΡΡΡΡ Π½ΠΎΠ·Π²ΠΎΠ»ΡΠ΅Π³ Π²Π°ΡΡΠΈΡΠΎΠ²Π°Π³Ρ ΡΠ²ΠΎΠΉΡΡΠ²ΠΎ Π»ΠΈΠΏΠΎΡΠΈΠ»ΡΡΡΠ³ΠΈ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΈΠΌΠ΅ΡΠ³ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π΄Π»Ρ ΠΏΠΎΡΡΡΠΎΠ΅Π½ΠΈΡ Π³Π΅ΠΎΡΠ΅Π³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ, ΠΏΡΠ΅Π΄ΡΠΊΠ°Π·ΡΠ²Π°ΡΡΠ΅ΠΉ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ Π»ΠΈΠΏΠΎΡΠΈΠ»ΡΡΡΠ³ΡΠΎ ΠΈ Π°ΡΠΈΠΌΠ°Π»ΡΡΠΈΠΉΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ Π΄Π»Ρ ΡΠΈΡΠΎΠΊΠΎΠ³ΠΎ ΠΊΡΡΠ³Π° 1,2,4-Π³ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π°Π³Π³Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΠ³Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°.
5. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ»ΡΡΡΠ΅Π½Π½ΠΎΡ ΠΌΠ΅ΡΠ΄Π° ΡΠΈΡΠ΅Π·Π° ΠΎΠ΄Π½ΠΎΡ ΠΈΠ· 1,2,4-ΡΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΡ Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π°ΡΡΠ΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π° ΠΈΡΡ ΠΎΠ΄Ρ ΠΈΠ· ΠΊΠΎΠΌΠΌΠ΅ΡΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΡΠΏΠ½ΡΡ ΡΠΈΠΊΠ»ΠΎΡΠ΅ΠΊΡΠ°Π½ΠΎΠ½Π° ΠΈ Π°ΡΠΈΠ»Π±ΡΠΎΠΌΠΈΠ΄Π° (5 ΡΠ³Π°Π΄ΠΈΠΉ, ΠΎΠ±ΡΠΈΠΌ Π²ΡΡ ΠΎΠ΄ΠΎΠΌ 9,3%), Π² ΠΊΠΎΡΠΎΡΠΎΠΌ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΡΡΡ Π±ΡΠ» ΡΠΎΠΊΡΠ°ΡΠ΅Π½ Π½Π° 2 ΡΡΠ΄ΠΈΠΈ, Π° ΡΡΠΌΠΌΠ°ΡΠ½ΡΠΉ Π²ΡΡ ΠΎΠ΄ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ Π² 2 ΡΠ°Π·Π°, Π½ΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΡΠ°Π½Π΅Π΅ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΠΎΡΠ»ΠΈΡΠ°Π΅ΡΡΡ oi ΡΠ°Π½Π΅Π΅ ΠΈΠ·Π²Π΅ΡΡΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π° Π²ΠΎΠ·Π΄ΡΡ Π° Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠ° ΡΠΈΠ½Π³Π»Π΅ΡΠΎΠ³ΠΎ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π° ΠΈ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ΠΌ Π½Π΅ ΡΠ»Π°Π²Π»ΠΈΠ²Π°Π΅ΠΌΡΡ ΡΠΊΡΠΈΡΠ½ΡΡ ΠΎΡΡ ΠΎΠ΄ΠΎΠ².
6. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° Π½ΠΎΠ²Π°Ρ ΡΠΈΡΠΏΠ΅Π³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡ Π΅ΠΌΠ°, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠ°Ρ ΠΏΠΎΠ»ΡΡΠ°ΡΡ ΠΏΡΠΈΠ½ΡΠΈΠΏΠΈΠ°Π»ΡΠ½ΠΎ Π½ΠΎΠ²ΡΠΉ ΡΠΈΠΏ ΡΡΡΡΠΊΡΡΡ: Π‘|2-ΡΡΠ»ΡΡΠΈΠ΄ΠΈ ΡΡΠ»ΡΡΠΎΠ½Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ 1,2,4-ΡΠΈΠΎΠΊΡΠ°Π½ΠΎΠ²ΡΠ΅ Π°Π½Π°Π»ΠΎΠ³ΠΈ Π°ΡΠ³Π΅ΠΌΠΈΠ·ΠΈΠ½ΠΈΠ½Π°. Π‘ΠΈΡΠ΅Π· Π΄Π°Π½Π½ΡΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ Π±ΡΠ» ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ Π² Π΄ΠΈΠ°ΡΡΠ΅ΡΠ΅ΠΎΠΌΠ΅ΡΠΏΠΎ ΡΠΈΡΡΠΉ ΡΠΎΡΠΌΠ΅, ΠΏΠΎΡΠ»Π΅ ΡΠ°Π·Π΄Π΅Π»Π΅Π½ΠΈΡ Π‘^-ΡΠ³ΡΠΈΠΌΠ΅ΡΠΎΠ² ΠΌΠ΅ΡΠ΄ΠΎΠΌ ΠΠΠΠ₯.
1. TDR News (News from the WHO Division of Control of Tropical Diseases) — 1994.-46.-p. 5.
2. Oaks S. C., Jr., Mitchell V. S., Pearson, G. W., Carpenter, Π‘. C., eds. Malaria: obstacles and opportunities. Washington, DC: National Academy Press, 1991.
3. Ziffer, II.- Ilighet, R. J.- Klayman, D. L. Artemisinin: an endoperoxidic antimalarial from Artemisia annua L. // Prog. Chem. Org. Nat. Prod. 1997. — 72, № 1 — p. 121.
4. Miller L II., Warrell D. A. Malaria. // Tropical and geographical medicine. K. S. Warren and A. A. F. Mahmoud, eds. New York: McGraw-Hill, 1990.
5. Luo X.-D., Ni M.Y., Fan J.-F., et al. Structure and reactions of arteannuin. // Acta Chim. Sinica. 1979. — 37, № 2. — p. 129.
6. Posner G. 11. Antimalarial peroxides in the qinghaosu (artemisinin) and ying/haosu families. // Hxp. Opin, Ther. Patents. 1998. — 8, № 7. — p. 1487−1493.
7. Posner G. Π., Parker M. II., Northrop J., et al. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family. //J. Med. Chem. 1999. — 42, № 2, p. 300−304.
8. Jung M., Lee S. Stability of acetal and non acetal-type analogs of artemisinin in simulated stomach acid. // Bioorg. Med. Chem. Lett. -1998.-8, № 5, p. 1003−1006.
9. Pu Y. M., Ziffer II. Synthesis and antimalarial activities of 12.beta.-allyldeoxoartemisinin and its derivatives. // J. Med. Chem. 1995. — 38, № 5.-p. 613−616.
10. Cumming J. N., Ploypradith P., Posner G. II. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism (s) of action. // Advances in Pharmacology. 1997. — 37. — pp. 253−297.
11. ΠΠ°i. 5 578 637 Π‘Π¨Π. Methods for inhibition or killing cancer cells using an endoperoxide / Lai II. C., Singh N. P. ΠΠΏΡΠ±Π». 26.11.1996.
12. Schmid G., Hofheinz W. Total synthesis of qinghaosu. // J. Am. Chem. Soc. 1983. — 105, № 5, p. 624−625.
13. Schulte Π. II., Ohloff G. // Ilelv. Chim. Acta. 1967. — 50. — p. 153.
14. McCullough K. J. Synthesis and use of cclie peroxides, i, Contemp. Org. Synth. 1995. — 2, № 3. — p. 225.
15. Buchi G., Wuest 11. // J. Am. Chem. Soc. 1977. 99. — p. 294.
16. Greene T. W., Wuts P. G. M. Protective groups in organic synthesis. 3rd lid. N. Y.: Wiley-Interscience, 1999.
17. Corey L.J., Suggs W. Pyridinium chlorochromate. An efficient reagent for oxidation of primary and secondary alcohols to carbonyl compounds. // Tetrahedron Lett. 1975. — 31, № 15. -p. 2647−2650.
18. Michael J. S., Dewar M. J. S., 'Ihiel W. MINDO/3 study of the addition of singlet oxygen (1 .DHLTA.g02) to 1,3-butadiene. // J. Am. Chem. Soc. 1977. — 99, № 7 — p. 2338−2339.
19. Xu X. X., Zhu J., Huang D. Z., Zhou W. S. Total synthesis of arteannuin and deoxyarteannuin. //Tetrahedron. 1986. — 42. — p. 819 828.
20. Avery M. A., Chong W. Π. M., Jennings-White C. Stereoselective total synthesis of (f)-artemisinin, the antimalarial constituent of Artemisia annua L. // Am. Chem. Soc. 1992. — 114. — p. 974−979.
21. Caine, D.- Procter, K.- Cassell, A. A facile synthesis of (-)-R-5-methyl-2-cyclohexen-l-one and related 2-substituted enones from (+)-pulegone. J. Org. Chem. — 1984. — 49. — p. 2647−2648.
22. Shapiro R. I I., Lipton M.F., Kolonko K.J. et al. Tosylhydra/ones and alkyllithium reagents: more on the regiospecificity of the reaction and the trapping of three intermediates. //Tetrahedron Lett. 1975. — p. 18 111 814.
23. Ravindranathan Π’., Kumar M. Π., Menon R. Π., I liremath S. V. Stereoselective synthesis of artemisinin. //Tetrahedron Lett.- 1990. -31. -p. 755−758.
24. Ilaynes R. K., Vonwiller S. C. From qinghao, marvelous herb of antiquity, to the antimalarial trioxane quinghaosu. Some remarkable new chemistry. // ΠΠ΅Π΅. Chem. Res. 1997. — 30. — p. 73−79.
25. Zaman S. S., Sharma R. P. Some aspects of the chemistry and biological activity of artemisinin and related antimalarials. // Heterocycles.- 1991.-32.-p. 1593−1638.
26. Xu X.-X., Zhu J., Huang D.-A., Zhou W.-S. 'I he stereocontrolled synthesis of arteannuin and deoxyarteannuin from arteannuic acid. // Acta Chem. Sinica. 1983. — 41. — p. 574.
27. Roth R. J., Acton N. A Simple conversion of artemisinic acid into artemisinin.//J. Nat. Prod. 1989. — 52. — p. 1183.
28. Roth R. J., Acton N. A facile semisynthesis of antimalarial drug qinghaosu //J. Chem. ltd. 1991. — 68.-p. 613.
29. Vroman J. A., Alvim-Gaston M., Avery M. A. Current progress in the chemistry, medicinal chemistry, and drug design of artemisinin based antimalarials.//Curr. Pharm. Design. 1999.-5.-p. 101−138.
30. Jung M., Lee K., Kim II., Park M. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents. // Curr. Med. Chem. -2004. 11.-p. 1265−1284.
31. Maggs J. L., Batty Π. Π’., Ilett K. F. et al. // Br. J. Clin. Pharmacol. -1998.-39.-p. 1533 1537.
32. Woo S. 11., Parker M. 11., Ploypradith P. et al. Direct conversion of pyranose anomeric OII-> F -> R in the artemisinin family of antimalarial trioxanes. //Tetrahedron Lett. 1998. — 39. — p. 1533 — 1536.
33. Matsumoto Π’., Hosoya Π’., Suzuki K. Improvement in O—>C-glycoside rearrangement approach to C-aryl glycosides: use of 1 -O-acetylsugar as stable but efficient glycosyl donor. // Tetrahedron Lett. 1990. 31.-p. 4629−4632.
34. O’Neil P. M., Miller A., Ward S. A. et al. Application of the TMSOTf-AgClO, activator system to the synthesis of novel, potent, C-10 phenoxy derivatives of dihydroartemisinin. //Tetrahedron Lett. 1999.40.-p. 9129−9132.
35. O’Neil P. M., Miller A., Bisop L. P. D. et al. Synthesis, antimalarial activity, biomimetic iron (U) chemistry, and in vivo metabolism of novel, potent Π‘-10-phenoxy derivatives of dihydroartemisinin. // J. Med. Chem. -2001.-44.-p. 58−67.
36. Ma J., Katz It., Kyle D. Π., Ziffer II. Syntheses and antimalarial activities of 10-substituted deoxoartemisinins. // J. Med. Chem. 2000. -43.-p. 4228−4236.
37. Burton J. W., Clark J. S., Derrer S. et al. Synthesis of medium ring ethers. 5. 'I he synthesis of (J)-laurencin. // J. Am. Chem. Soc. 1997.32.-p. 7483−7498.
38. Jung M., Freitas Π. Π‘. C., McChensey J. D.- HlSohly II. N. A practical and general synthesis of (+)-carboxyalkylartemisinins. // I Ieterocycles. 1994. — 39. — p. 23 — 29.
39. Ilaynes R. K., Vonwiller S. C. Efficient preparation of novel quinghaosu (artemisinin) derivatives: conversion of qinghao (artemisinic) acid into deoxoqinghaosu derivatives and 5-carba-4-deoxoartesunic acid. // Synlett. 1992. -p. 481−483.
40. Jung M., Lee S. A concise synthesis of novel aromatic analogs of artemisinin. //1 Ieterocycles. 1997. — 45. — p. 1055−1058.
41. Jung M., Lee S. An efficient synthesis of novel spirodeoxoartemisinin with 2-pyrazoline ring. // I Ieterocycles. 1997. -45.-p. 1907;1911.
42. Paitayatat S., Tarnchompoo Π., Thebtaranonth Y., Yuthavong Y. Correlation of antimalarial activity of artemisinin derivatives with bindingaffinity with ferroprotoporphyrin IX. // J. Med. Chem. 1997. — 40. — p. 633−638.
43. Avery M. A., Fan P., Karle J. M. et al. Replacement of the nonperoxidic trioxane oxygen atom of artemisinin by carbon: total synthesis of (+)-13-carbaartemisinin and related structures. //Tetrahedron Lett. 1995.-36.-p. 3965−3968.
44. Ohsugia S.-I., Nishidea K., Oonob K. et al. New odorless method for the Corey-Kim and Swern oxidations utilizing dodecyl methyl sulfide (Dod-S-Me). // 'Tetrahedron. 2003. — 59. — p. 8393−8398.
45. I leathcock Π‘. II., Hllis J. E., McMurry J. E., Coppolino A. Acid-catalyzed robinson annelations. // 'Tetrahedron Lett. 1971. — 12. — p. 4995−4996.
46. G. II. Posner An Introduction to synthesis using organocopper reagents. New York: Wiley, 1980.
47. Ploypradith, P. Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs. // Acta Trop. 2004. -89.-p. 329−342.
48. Corey E. J., Mehrotra M. M., Khan A. U. Generation of 'Ag 02 from triethylsilane and o/one. // J. Am. Chem. Soc. 1986. — 108. — p. 24 722 473.
49. Posner G. II., Webb K. S., Nelson W. M. et al. A new oxidizing reagent: triethylsilyl hydrotrioxide. // J. Org. Chem. 1989. — 54. — p. 3252−3254.
50. Synglet oxygen. Wassermann, II. F., Murray, R. W., Eds. New York: Academic Press, 1979.
51. Jefford Π‘. W., Velarde J., Bernardinelli G. Synthesis of tricyclic arteannuin-like compounds. Tetrahedron Lett. — 1989. — 30. — p. 44 854 488.
52. Posner G. II., Oh Π‘. II., Milhous W. K. Olefin oxidative cleavage and dioxetane formation using triethylsilyl hydrotrioxide: applications to preparation of potent antimalarial 1,2,4-trioxanes. // Tetrahedron Lett. -1991.-32.-p. 4235−4238.
53. Posner G. II., Oh Π‘. II., Gerena L., Milhous W. K. Synthesis and antimalarial activities of structurally simplified 1,2,4-trioxanes related to artemisinin //1 Ieteroatom Chemistry. 1995. — 6. — p. 105−116.
54. Oh Π‘. II., Wang D., Gumming J. N., Posner G. II. Antimalarial 1,2,4-trioxanes related to artemisinin: rules for assignment of relative stereochemistry in diversely substituted analogs. // Spectroscopy Lett. -1997.-30.-p. 241−255.
55. Posner G. II., Oh Π‘. II., Gerena L., Milhous W. K. Extraordinarily potent antimalarial compounds: new, structurally simple, easily synthesized, tricyclic 1,2,4-trioxanes. // J. Med. Chem. 1992. — 35. — p. 2459−2467.
56. Posner G. II., McGarvey D. J., Oh Π‘. II. et al. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin. // J. Med. Chem. 1995. — 38. — p. 607−612.
57. Oh Π‘. II., Kang J. II., Posner G. II. A short synthesis of 6,9-desmethyldeoxoartemisinin and its isomer. // Bull. Korean Chem. Soc. -1996. 17.-p. 581−582.
58. Oh Π‘. II., Posner G. II. Syntheses and iron (II) induced reactions of phenyl-substituted 1,2,4-trioxanes. // Bull. Korean Chem. Soc. 1997. -18.-p. 644−648.
59. Abraham R. J., Fisher J., Loftus P. Introduction to NMR Spectroscopy. Chichester, UK: John Wiley, 1990. — Chapter 3, Section 5.
60. Posner G. II., Cumming J. N., Woo S.-II. et al. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation. // J. Med. Chem. 1998. — 41. — p. 940−951.
61. Cumming J. N., Wang D., Park S. B. et al. Design, synthesis, derivati/ation, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin. // J. Med. Chem. 1998.-41.-p. 952−964.
62. Posner G. 11., Wang D., Gonzalez L. et al. Mechanism-based design of simple, symmetrical, easily prepared, potent antimalarial endoperoxides. //Tetrahedron Lett. 1996. — 37. — p. 815−818.
63. Posner G. 11., Gonzalez L., Cumming J. N. et al. Synthesis and antimalarial activity of heteroatom-containing bicyclic endoperoxides. //Tetrahedron. 1997. — 53. — p. 37−50.
64. Takashi Y., Okitsu O., Ando M., Miyashi T. Hlectron-transfer induced intramolecular |2 -t 2. cyloaddition of 2,6-Diarylhepta-l, 6-dienes Tetrahedron Lett. 1994. — 35. — p. 3953−3956.
65. Tebbe F. N., Parshall G. W., Reddy G. S. Olefin homologation with titanium methylene compounds. // J. Am. Chem. Soc. 1978. — 100. — p. 3611−3613.
66. Desjardins R. I:., Canfield C. J., Ilaynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by asemiautomated microdilution technique. // Antimicrob. Agents Chemother. 1979. — 16. — p. 710−718.
67. Milhous W. K., Weatherly N. F., Bowdre J. II., Desjardins R. E. // Antimicrob. Agents Chemother. 1985. — 27. — p. 525−531.
68. Posner G. Π., Tao X., Cumming J. N. et al. Antimalarial^ potent, easily prepared, fluorinated endoperoxides. // Tetrahedron Lett. 1996. -37.-p. 7225−7228.
69. Adam W., Balci M. Photooxegynation of 1,3,5-cyclopentatriene: isolation and characterization of endoperoxides. // J. Am. Chem. Soc. -1979.-101. 7537−7541.
70. Posner G. II., O’Dowd II., Ploypradith P. et al. Antimalarial cyclic peroxy ketals. // J. Med. Chem. 1998. — 41. — p. 2164−2167.
71. Posner G. II., O’Dowd II. An antimalarially active cyclic peroxy ketal. //1 Ieterocycles. 1998. — 47. — p. 643−646.
72. Ricard R., Sauvage P., Wan C. S. K. et al. Photochemical enoli/ation of P-alkyl «^-unsaturated ketones. J. Org. Chem. 1986. -51.-p. 62−67.
73. Snider Π. Π., Shi Z. Total synthesis of (±)-chondrillin, (i)-plakorin, and related peroxy ketals. // J. Am. Chem. Soc. 1992. — 114. — p. 17 901 800.
74. Snider Π. Π., Shi Z., O’Neill S. V. et al. Stereochemical dependence of base-cataly/ed cleavage of cyclic peroxy ketals. // J. Org. Chem. -1994. -59.-p. 1726−1729.
75. Bachi M. D., Korshin H. K. Thiol-oxygen cooxidation of monotrpenes. synthesis of endoperoxides structurally related to antimalarial yingzhaosu A. // Synlett. 1998. — p. 122−124.
76. Bachi M. D., Korshin H. H., Ploypradith P. et al. Synthesis and in vitro antimalarial activity of sulfone endoperoxides. // Bioorg. Med. Chem. Lett. -1998. 8. — p. 903−908.
77. Posner G. II., O’Dowd II., Caferro T. et al. Antimalarial sulfone trioxanes. // Tetrahedron Lett. 1998. — 39. — p. 2273−2276.
78. Posner G. 11., Maxwell J. P., O’Dowd 11, et al. Antimalarial sulfide, sulfone, and sulfonamide trioxanes. // Bioorg. Med. Chem. 2000. — 8. -p. 1361−1370.
79. Bartlett P. D., Chu II.-K. Mechanism of the direct reaction of phosphite o/onides with olefins. // J. Org. Chem. 1980. — 45. — p. 30 003 004.
80. Bartlett P. D., Mendenhall G. D., Durham D. L. Controlled generation of singlet oxygen at low temperature from triphenyl phosphite ozonide. // J. Org. Chem. 1980. — 45. — p. 4269−4271.
81. Mendenhall G. D., Priddy D. B. A reexamination of the o/one-triphenyl phosphite system. The origin of triphenyl phosphate at low temperatures. // J. Org. Chem. 1999. — 64. — p. 5783−5786.
82. Lee I. S., HI Sohly II. N., Croom E. M., Ilufford C. D. Microbial metabolism studies of the antimalarial sesquiterpene artemisinin. // J. Nat. Prod. 1989.-52.-p. 337−341.
83. Vennerstrom J. L., Eaton J. W. Oxidants, oxidant Drugs, and malaria. J. Med. Chem. 1988. — 31. — p. 1269−1277.
84. Posner G. II., Oh Π‘. II. A regiospecifically oxyge-18 labeled 1,2,4-trioxane: A simple chemical model system to probe the mechanism (s) of the antimalarial activity of artemisinin (qinghaosu). // J. Am. Chem. Soc. 1992.-114.-p. 8328−8329.
85. Posner G. II., Park S. Π., Gon/alez L. et al. Evidence for the importance of high-valent Fe=0 and of a diketone in the molecularmechanism of action of antimalarial trioxane analogs of artemisinin. //J. Am. Chem. Soc. 1996. — 118. — p. 3537−3538.
86. Robert A., Meunier B. Characterization of the first covalent adduct between artemisinin and a heme model // J. Am. Chem. Soc. 1997. -119.-p. 5968−5969.
87. Robert A., Meunier B. Is alkylation the main mechanism of action of the antimalarial drug artemisinin? // Chem. Soc. Rev. 1998. — 27. — p. 273−279.
88. Posner G. 11., Cumming J. N., Ploypradith P., Oh Π‘. 11. Evidence for Fe (IV)=0 in the molecular mechanism of action of the trioxane antimalarial artemisinin. // J. Am. Chem. Soc. 1995. — 117. — p. 58 855 886.
89. Bharel S., Vishwakarma R. A., Jain S. K. Artemisinin mediated alteration of haemin to a 5-meso oxidation product: relevance to mechanism of action. // J. Chem. Soc. Perkin Trans. 1. 1998. — p. 21 632 166.
90. Wu W.-M., Yao Z.-J., Wu Y.-L. et al. Ferrous ion induced cleavage of the peroxy bond in qinghaosu and its derivatives and the DNA damage associated with this process. //Chem. Commun. 1996. — p. 2213−2214.
91. Sadava D., Phillips Π’., Lin C., Kane S. E. Transferrin overcomes drug resistance to artemisinin in human small cell lung carcinoma cells. // Cancer Lett. 2002. — 179. — p. 151 -156.
92. Lai II. C., Singh N. P. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995. -91. — p. 41−46.
93. I lai. 5 578 637 Π‘Π¨Π. Methods of inhibition or Killing Cancer Cells Using an Hndoperoxide. / Lai 11. C., Singh, N. P. ΠΠΏΡΠ±Π». 08.09.1996.
94. Woerdenbag, II. J. et al. Cytotoxicity of artemisinin-related endoperoxides to HAT cells. // J. Nat. Prod. 1993. — 56. — p. 849−856.
95. Posner G. II., Nelson T. D., Guton K. Z., Kensler, T. W. New vitamin D3 derivatives with unexpected antiproliferative activity: 1-(hydroxymethyl)-25-hydroxyvitamin D3 homologs. // J. Med. Chem. -1992.-35.-p. 3280−3287.
96. Posner G. 11., Ploypradith P., I Iapangama W. et al. Trioxane dimers have potent antimalarial, antiproliferative, and antitumor activities in vitro. // Bioorg. Med. Chem. 1997. — 5. — p. 1257−1265.
97. Posner G. II., Ploypradith P., Parker M. II. et al. Antimalatial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. // J. Med. Chem. 1999. 42. — p. 4275−4280.
98. Jung M., Lee S., I lam J. et al. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer. // J. Med. Chem. 2003. 46. p. 987−994.
99. Posner G. II., Paik I.-II., Sur S. et al. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. //J. Med. Chem. 2003. — 46. — p. 1060−1065.
100. Jeyadevan J. P., Bray P. G., Chadwick J. et al. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10P-(2-hydroxyethyl)deoxoartemisinin. // J. Med. Chem. 2004. — 47. — p. 12 901 298.
101. Stork G., Bri//olara A., Landesman II. et al. 'I he enamine alkylation and acylation of carbonyl compounds. // J. Am. Chem. Soc. -1963.-85.-p. 207−222.
102. Ilam/aoui M., Provot O., Camu/t-Dedenis B. et al. Wittig reaction: a new route to a-methoxyketones. application to the synthesis of simplified analogs of artemisinin. // Tetrahedron Lett. 1998. — 39. — p. 4029−4030.
103. Wang X., Rabbat P., O’Shea P. et al. Selective monolithiation of 2,5-dibromopyridine with butyllithium. // Tetrahedron Lett. 2000. — 41. -p. 4335−4338.
104. Tanino K., Katoh 'I'., Kuwajima I. A highly selective one-carbon ring enlargement reaction directed by silicon. // Tetrahedron Lett. 1988. 29. p. 1815−1818.
105. Ley S. V., Norman J., Griffith W. P., Marsden S. P. Tetrapropylammonium perruthenate, Pr4NTRuO, 'ΠΠ ΠΠ : a catalytic oxidant for organic synthesis. // Synthesis. 1994. — p. 639−657.
106. Mascarenas J.-L., Perez-Sestelo J., Castedo L., Mourino Π. Π short, flexible route to vitamin D metabolites and their side chain analogues. // Tetrahedron 1, ett. 1991. 32. — p. 2813−2816.
107. Ilaynes R. K., Vonwiller S. C. The behaviour of qinghaosu (artemisinin) in the presence of non-heme iron (II) and (III). //Tetrahedron Lett. 1996.-37.-p. 257−260.
108. Fadel A., Salaun J., Conia J. M. Small ring compounds — XLI: cyclobutene cycloadditionssynthesis and reactivity in the bicyclo2.2.0.hexan-2-one series. // Tetrahedron. 1983. — 39. — p. 15 671 574.
109. ΠΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΡΠΉ naieni W00059501. Synthesis and activity of water-soluble trioxanes as potent and safe antimalarial agents. / Posner G. II., Parker, M. II., Krasavin M., Shapiro Π’. A. ΠΠΏΡΠ±Π». 06.06.2000.
110. I lai. 6 136 847 Π‘Π¨Π. Water-soluble trioxanes as potent and safe antimalarial agents. / Posner G. 11., Parker M. H., Krasavin M., Shapiro T. Π.-ΠΠΏΡΠ±Π». 16.08.2000.
111. Posner G. II., Weitzberg M., Nelson W. M. et al. 1,2-Dioxetanes from vinyl aromatics. // J. Am. Chem. Soc. 1987. — 109. — p. 278−279.
112. Carless II. A. J., Billinge J. R., Oak O. Z. Photochemical routes from arenes to inositol intermediates: the photo-oxidation of substituted cis-cyclohexa-3,5-diene-l, 2-diols. // Tetrahedron Lett. 1989. — 30. — p. 3113−3116.
113. Mirjalili Π. F, Zolfigol M. Π., Bamoniri A., Zarei A. Silica sulfuric acid/potassium permanganate/wet S1O2 as an efficient heterogeneous method for the oxidation of alcohols under mild conditions. // Bull. Korean Chem. Soc. 2003. — 24. — p. 400−402.
114. Avery M. A., Mehrota S., Bonk J. D. et al. Structure-activity relationships of the antimalarial agent artemisinin. 4. effect of substitution at C-3. // J. Med. Chem. 1996. — 39. — p. 2900−2906.
115. Posner G. II., Jeon II. Π., Parker M. II. et al. Antimalarial simplified 3-aryltrioxanes: synthesis and preclinical efllcacy/toxicity testing in rodents. // J. Med. Chem. 2001. — 44. — p. 3054−3058.
116. Trabanco A. A., Montalban A. G., Rumbles G. et al. A seco-porphyrazine: superb sensitizer for synglet oxygen generation and endoperoxide synthesis. // Synlett. 2000. — 7. — p. 1010−1012.
117. Wang D. Ph. D. thesis. The Johns I lopkins University, 1996.
118. McDougal P. G., Rico J. G., Oh Y. I., Condon B. D. A convenient procedure for the monosilylation of symmetric l, n-diols. // J. Org. Chem. 1986.-51.-p. 3388−3390.
119. Ploypradith P. Ph. D. thesis. The Johns I lopkins University, 1999. -p. 157.